Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in VERU — Veru Inc.

CIK 1362033 LONDON, X0
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$492,461
+$73,227 QoQ
Shares Held
157,336
-17.1% QoQ
Ownership
0.923%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#6
of 61 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. VERU ranks #77 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 14,986,947 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in VERU

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $492,461 157,336
2026-03-31 $419,234 189,699
2025-12-31 $418,789 195,696
2025-09-30 $616,458 162,226
2025-03-31 $7,339 14,978
2022-03-31 $87,683 18,154
2021-12-31 $208,529 35,404
2021-09-30 $919,943 107,848
2020-12-31 $1,164,177 134,587
2020-09-30 $642,141 245,092
2020-06-30 $207,828 62,224